Approval enables European HLA laboratories and those beyond Europe requiring CE mark to adopt differentiated Next Generation Sequencing (NGS) solution for HLA typing
Work conducted at Center to revolutionize diagnosis and treatment of cancer globally, selects Thermo Fisher Scientific as technology partner
New next generation sequencing-based proteomics kits designed to integrate with multiple NGS platforms, eliminating the need for new instrumentation or specialized expertise
The new instrument aims to further democratize the adoption of liquid handling automation for NGS applications
The combined offering is designed to provide researchers with high quality tools to diagnose cancer and selected genetic disease
Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
Join us on Thursday, June 18, to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
Convenient blood test uses novel technology to test for recurrence of tumors by detecting circulating DNA
Genome in a Bottle Consortium Data Submission for Webinar Presentation and Public Availability
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
Through advanced genetic algorithms and supercomputing, scientists have discovered how genetic diseases such as cancer systematically attack the networks controlling human cells, according to a pair of papers published back-to-back in CELL.
